Streetwise Reports' Article Archives — May 2020 back to current month (129)
Patriot One Technologies and its partners have created a model that automatically calculates, from a radiological scan, the degree of a patient's affected lungs, a COVID-19 indicator.
UGE International Ltd. reported that it has signed agreements to develop, build and finance three community solar projects in Maine.
In conversation with Maurice Jackson of Proven and Probable, Jayant Bhandari of Capitalism and Morality offers his take on what the post-COVID-19 world will look like.
Technical analyst Clive Maund charts Black Tusk Resources and explains why he sees it as an "immediate strong speculative buy."
Shares of Zscaler Inc. set a new 52-week high price after the company reported that it was selected by the U.S. DoD's Defense Innovation Unit for a secure cloud management project.
Metallic Minerals defines and refines targets at the Yukon project.
Canadian Explorer Closes Yukon Project Acquisition (05/28/2020)
Seabridge Gold intends to initiate data collection and analysis on this orogenic gold asset.
Xtract AI, a subsidiary of Patriot One Technologies Inc., has secured a contract valued at CA$157,000 with Canada's National Defense Department's Public Works and Government Services Division to improve situational awareness for Canadian firefighters.
Newrange Gold Corp. reported that it will begin drilling this week at its Pamlico Gold project in Nevada.
Once the deal for the final 20% closes, Aftermath Silver will begin exploration there.
Patriot One Technologies' Vancouver-based artificial intelligence team will work on improving concealment of soldiers and their vehicles in the field.
Tech Firm to Partner with Wallet Pass Developer (05/28/2020)
The partnership will facilitate Loop Insights' entrance into additional and international markets.
Colorado Uranium Firm Restarting Mining Activities (05/28/2020)
Western Uranium & Vanadium is preparing its team to commence mining in compliance with state COVID-19 requirements.
Dollar Tree shares traded higher after the firm reported Q1/20 financial results that included an 8.2% y-o-y increase in consolidated net sales fueled by a 15% y-o-y increase in same-store sales at its Family Dollar locations.
Money manager Adrian Day reviews developments, both positive and not-so-positive, at several companies in his portfolio and he finds that some are cheap enough to buy.
Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil.
Imagin Medical delivered two functional i/Blue™ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists.
Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report.
The goal of Sorrento Therapeutics to develop a Covid-19 antibody cocktail, including its progress, next steps and market opportunity, is reviewed in a Dawson James report.
Peter Epstein of Epstein Research explains why he is "bullish" on Falcon Gold Corp., with five Canadian projects targeting mostly gold, but also silver, copper, cobalt, nickel and platinum group metals.
Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer.
Bob Moriarty of 321gold discusses the company's plans to explore its silver project in Nevada's second largest silver district.
With the deal, Ely Gold Royalties will gain a 3% net smelter returns royalty on future production.
The Inflation–Deflation Conundrum (05/26/2020)
Sector expert Michael Ballanger considers what the post-pandemic world could look like in the aftermath of central bank actions.
Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373.
With CBD showing some promise against Covid-19 and cannabis stocks rising, Peter Epstein of Epstein Research discusses the market with Sweet Earth Holdings executives.
The New Age of Advertising (05/26/2020)
Ron Struthers of Struthers Resource Stock Report profiles a company with a "robust reward based advertising platform that is now focused on the gaming industry."
White Gold Has a World of Riches Few Understand (05/23/2020)
Bob Moriarty of 321gold discusses a company with 33 projects in the Yukon.
Shares of Splunk Inc. established a new 52-week high price after the company reported Q1/21 financial results that included an 81% year-over-year increased in Cloud revenues.
Analysts say MAG Silver offers production as well as exploration upside.
FansUnite Entertainment aims to grow the platform's membership base and increase its betting volume.
With this sale, Avivagen's antibiotics-free, immune-boosting feed additive enters the Mexican market.
Nexus Gold agreed to purchase two additional mineral claims adjacent to its McKenzie Gold project in Red Lake, Ontario.
Rick Mills of Ahead of the Herd asks if it's possible to rescue the economy while also making big cuts to greenhouse gas emissions and improving overall health, and discusses one company with a large lithium deposit that could go a long way to providing U.S.-sourced material for batteries.
Why Silver Stocks Should Be on Investors' Radar (05/21/2020)
Technical analyst Clive Maund explains why he believes investors should be looking at silver right now.
Though gasoline demand remains historically weak, commuters are beginning to head back to their offices, opting for the isolation of their personal vehicles and abandoning public transit, reports McAlinden Research.
Shares of BJ's Wholesale Club Holdings reached a new 52-week high price today after the company reported that comparable club revenues in Q1/20 excluding gasoline sales increased by 27% year-over-year.
Loop Insights' contactless solutions, such as ID verification and digital receipts, are especially relevant in the era of Covid-19.
Patriot One Technologies is adding health safety modules to its threat detection platform.
These kits, which include VSBLTY Groupe Technologies' software, are helping cities control crime and enforce COVID-19-related crowd restrictions.
Seabridge Gold's goal is to determine if the Iskut property contains a copper-gold porphyry system.
Gold Terra Resource noted that some of the holes showed the widest gold intersections ever drilled at the target.
With its work on this and a SARS-CoV-2 test, ProMIS Neurosciences is applying its technology platform in new ways.
Loop Insights entered into an agreement with Sun Global Broadband to promote international tourism and public safety in Hawaii and to deliver contactless solutions for the 2021 Summer Olympic Games in Tokyo.
Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients.
Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report.
Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug.
Adrian Day: Three Undervalued Resource Companies (05/19/2020)
Money manager Adrian Day reviews developments at three gold and silver companies in his portfolio.
Imagin Medical reported that its actions have mitigated the impact of the coronavirus on its business operations.
Sector expert Michael Ballanger anticipates the come-from-behind winning run of silver.
Taiga Gold Corp. Will Be Bought Out (05/18/2020)
Bob Moriarty of 321gold discusses why he believes the spin-off company will be bought out.
Money manager Adrian Day looks at three large gold royalty companies that have reported Q1 earnings.
Shares of Moderna Inc. traded higher, setting a new 52-week high price, after the firm reported positive interim results in its Phase 1 study of mRNA Vaccine (mRNA-1273) against SARS-CoV-2.
Algernon Pharmaceuticals intends to test a repurposed drug for this indication, in a trial in three countries.
Sproutly Canada has received capital investment from Infusion Biosciences.
Bob Moriarty: This Time It's Different (05/18/2020)
In this conversation, Bob Moriarty of 321gold and Maurice Jackson of Proven and Probable discuss the coronavirus, the stock market, what lies ahead for gold and silver, and junior mining companies with potential.
Defense Metals in the Right Spot at the Right Time (05/16/2020)
Bob Moriarty of 321gold discusses this company that is exploring a rare earth element project in Canada.
Peter Epstein of Epstein Research explains why he is watching this explorer.
Shares of Aurora Cannabis traded 60% higher after the company reported an 18% rise in net revenue, which included a 24% increase in consumer sales versus to the prior quarter.
A Haywood report explains why TORC Oil & Gas is "well positioned to ride out the current tumultuous oil price environment."
Devon Energy's first quarter operational and financial numbers are reviewed and a 2020 cash flow forecast are provided in a Raymond James report.
Group Ten Metals reports that soil geochemistry results suggest the presence of a strongly mineralized system at its Montana asset.
ProMIS Neurosciences advances its various antibody programs related to neurodegenerative diseases and viral infections such as Covid-19.
Gold Explorer Begins Work at Quebec Gold Property (05/14/2020)
Black Tusk Resources reported that it has begun work on the McKenzie East Gold project located near Val-D'or, Quebec.
McAlinden Research Partners reports that hedge funds that had been shorting natural gas have suddenly developed a strong appetite for natural gas stocks and bonds on the expectation that U.S. oil wells that generate gas as a by-product will close fast enough to make up for the collapse in global natural gas demand.
Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial.
Low-Cost Oil & Gas Producer Posts Strong Q1/20 (05/14/2020)
At quarter's end, Pan Orient Energy states it is in a solid financial position.
Gold Explorer Recaps Q1/20 Corporate Activities (05/14/2020)
Liberty Gold sold two assets and advanced its Idaho project.
Defense Metals reports a 49% increase in tonnage and a 30% increase in overall average grade.
This development benefits Alvopetro Energy in a globally uncertain time.
Weimar Fed in the Twenty-First Century (05/14/2020)
Sector expert Michael Ballanger expands on both the latest money market moves and his investment thesis for Getchell Gold.
The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report.
Testing and validation of ProMIS Neurosciences' antibody targets will be conducted over the coming weeks.
Black Tusk Resources' receives the okay to construct 18 drill pads.
Ely Gold Royalties reported that its common shares are now listed for trading on the OTC Markets Group's OTCQX marketplace.
Shares of United Natural Foods traded higher, setting a new 52-week high, after the company reported preliminary financial results for Q3/20, which demonstrated a 12% growth in y-o-y revenue and a 43% increase in earnings per share.
Gold Terra Resource Corp. reported results for 10 drill holes from Sam Otto South at its 100%-owned Yellowknife City Gold project.
Nexus Gold will first focus on known areas of high-grade mineralization in the southernmost part of its claim block.
Sports Betting Tech Firm Outlines 2020 Strategy (05/12/2020)
FansUnite Entertainment's primary goals are to grow globally and create shareholder value.
Finding Solar Opportunity in the Pandemic Downturn (05/12/2020)
Small-cap UGE International boasts a $50 million project backlog and a $250 million pipeline.
Technical analyst Clive Maund discusses why he is upbeat about Tanzanian Gold.
Brien Lundin, sector expert and publisher of the Gold Newsletter, offers his perspective on the monetary ramifications of the COVID-19 pandemic in this conversation with Maurice Jackson of Proven and Probable.
Shares of cloud platform company Datadog Inc. traded higher and established a new 52-week high price after the firm reported an 87% increase in Q1/20 year-over-year revenue.
Peter Epstein of Epstein Research profiles the company that has the only permitted, primary cobalt refinery in North America.
Black Tusk Resources continues gathering and assessing data on the polymetallic property.
Eguana Technologies reported it received an additional $1.8 million in purchase order releases from Hanwha Q Cells and has restarted production at its contract manufacturing facility in Italy.
Defense Metals is working toward updating its mineral resource.
Technical analyst Clive Maund explains why he's bullish on silver.
Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy.
Technical expert Clive Maund explains why he believes gold and silver are powering up for a stratospheric advance.
Algernon Pharmaceuticals reported that it has received ethics approval in Australia for a Phase 2 human clinical study of NP-120 (Ifenprodil) for use in treatment of idiopathic pulmonary fibrosis and chronic cough.
Shares of Protagonist Therapeutics traded higher and reached a new 52-week high price after the company released Q1/20 financial results and positive data from its Phase 2 study of PTG-300 in patients with polycythemia vera, a type of blood cancer.
Product shipments by Eguana Technologies are up over the last fiscal year.
Outcrop Gold expects the 120-hole, 13,000 meter program to extend into Q1/21.
Additional resource potential exists at Gold Standard Ventures' project in the Battle Mountain Trend.
In light of COVID-19, brick and mortar retailers can benefit from Loop Insights' offering.
Black Tusk Resources has expanded the land package around its PG Highway Property's Palladium/Platinum Group Elements project to 20 claims covering 1,052.3 hectares.
A recap of Parsley Energy's Q1/20 performance and projections for this year and next are given in a Raymond James report.
While the broader markets have seen sharp declines, Frank Holmes, CEO and chief investment officer of U.S. Global Investors, homes in on gold, gold stocks and bitcoin, and gives his prognosis for the airlines.
UGE International completes its transition to working solely on self-developed projects.
Goldcliff Resource also acquires 16 claims to expand its property there.
Energy Fuels will have the exclusive right to use, license and service the technology globally.
This arrangement will bolster the use of CloudMD Software & Services' software in the United States.
Knox Henderson discusses the rise of online sports engagement platforms during stay-at-home orders and provides an update on FansUnite since it began trading on Tuesday.
Shares of ION Geophysical traded higher after the company reported Q1/20 financial results that included a 53% year-over-year increase in revenue.
Peter Epstein of Epstein Research looks into the Gross Overriding Royalty that just changed hands on the company's flagship Red Hill project, and discusses what it means for the firm.
Building a Better Covid-19 Antibody Test (05/06/2020)
ProMIS is harnessing its unique technology platform to develop a more error-free antibody test.
Arcturus Therapeutics Holdings' arrangement is explained and commented on in an H.C. Wainwright & Co. report.
ProMIS Neurosciences' antagonists prevent dysfunctional protein aggregation.
Shares of Horizon Therapeutics traded higher setting a new 52-week high price after the company reported a 27% y-o-y increase in net sales for Q1/20 and raised FY/20 net sales guidance.
Aben Resources has identified multiple targets at the Forrest Kerr Gold Project in British Columbia's Golden Triangle.
The junior gold explorer with a nascent exploration breakthrough could soar on the back of a gold bull market, writes Peter Krauth.
This company, active in the gaming industry since 2014, has just gone public and is looking to unleash its own high-growth consolidation strategy.
Firm Reports Gold Discovery in New Brunswick (05/05/2020)
Mineralization suggests the presence of an epithermal system at this project of X-Terra Resources.
CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms.
Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals.
Newrange Gold is preparing to restart operations as soon as COVID-19 restrictions are eased.
Megastar Development agrees to extend the due date of the final payment until year-end 2020.
Use of CloudMD Software & Services' health solution is seeing significant growth.
Lion One Metals plans to have three rigs at work there during the dry season.
ProMIS Neurosciences reported it has generated novel intrabodies that are highly selective for misfolded forms of TAR DNA-binding protein 43 implicated in several neurologic disorders.
Pretium Resources' flagship mine continues to generate free cash flow.
No Respect (05/04/2020)
Sector expert Michael Ballanger reflects on how Rodney Dangerfield's famous one-liner applies to today's gold market.
Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million.
The Second Massive Downwave Is Almost Upon Us (05/04/2020)
Technical analyst Clive Maund charts the markets and discusses what he believes is ahead for stocks, the dollar and commodities.
Great Bear Resources finished drilling one-third of the planned holes for the LP Fault at its project in Ontario.
Gold: $6,600 or $22,000 (05/03/2020)
Bob Moriarty of 321gold discusses economic collapse and gold.
The company has achieved its full-year contract sales target in four months.
Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEV™ in its first full quarter of sales.
|"NAU continues to be a Buy in this area, especially on any dips back."|
|"POE is sold! After years of waiting, it is finally becoming a reality."|
|"OCG confirmed another high-grade discovery at Santa Ana."|
|"AGN looks like it is shaping up for a breakout into a new bull market."|
|"It looks like we are going to see upside action in DAC."|